Literature DB >> 8798447

Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors.

L Laflamme1, M Gasparo, J M Gallo, M D Payet, N Gallo-Payet.   

Abstract

In the present study, 3-day treatment of nondifferentiated NG108-15 cells with 100 nM angiotensin II (Ang II) induces morphological differentiation of neuronal cells characterized by the outgrowth of neurites. These morphological changes are correlated with an increase in the level of polymerized tubulin and in the level of the microtubule-associated protein, MAP2c. Mediation by the AT2 receptor may be inferred since: (a) these cells contain only AT2 receptors; (b) the effects are mimicked by CGP 42112 (an AT2 receptor agonist); (c) they are not suppressed by the addition of DUP 753 (an AT1 receptor antagonist); and (d) are abolished by co-incubation with PD 123319 (an AT2 receptor antagonist). Application of Ang II in dibutyryl cAMP-differentiated cells (which contain both types of receptors) induces neurite retraction, an effect mediated by the AT1 receptor. These results indicate that the AT2 receptor of Ang II induces neuronal differentiation, which is initiated through an increase in the levels of MAP2c associated with tubulin. Moreover, our results demonstrate that the AT1 receptor inhibit the process of differentiation induced by dibutyryl cAMP, whereas the AT2 receptors potentiate this effect, illustrating negative cross-talk interaction between the two types of Ang II receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798447     DOI: 10.1074/jbc.271.37.22729

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?

Authors:  Philip Rosenstiel; Stefan Gallinat; Alexander Arlt; Thomas Unger; Jobst Sievers; Ralph Lucius
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

4.  Saralasin and Sarile Are AT2 Receptor Agonists.

Authors:  Marie-Odile Guimond; Mathias Hallberg; Nicole Gallo-Payet; Charlotta Wallinder
Journal:  ACS Med Chem Lett       Date:  2014-08-18       Impact factor: 4.345

5.  Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.

Authors:  Charlotta Wallinder; Christian Sköld; Milad Botros; Marie-Odile Guimond; Mathias Hallberg; Nicole Gallo-Payet; Anders Karlén; Mathias Alterman
Journal:  ACS Med Chem Lett       Date:  2014-12-08       Impact factor: 4.345

6.  Neuroprotection after traumatic brain injury in heat-acclimated mice involves induced neurogenesis and activation of angiotensin receptor type 2 signaling.

Authors:  Gali Umschweif; Dalia Shabashov; Alexander G Alexandrovich; Victoria Trembovler; Michal Horowitz; Esther Shohami
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-21       Impact factor: 6.200

Review 7.  Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions.

Authors:  Yong Li; Pablo Gonzalez; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2012-05-22       Impact factor: 11.685

Review 8.  X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates [Ca²⁺]i.

Authors:  Benjamin L Prosser; Ramzi J Khairallah; Andrew P Ziman; Christopher W Ward; W J Lederer
Journal:  J Mol Cell Cardiol       Date:  2012-12-06       Impact factor: 5.000

Review 9.  Are angiotensin receptor blockers neuroprotective?

Authors:  Christa Thöne-Reineke; Mathias Zimmermann; Christian Neumann; Maxim Krikov; Jun Li; Nadja Gerova; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

10.  Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth.

Authors:  M Akishita; M Ito; J Y Lehtonen; L Daviet; V J Dzau; M Horiuchi
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.